nach oben

Erschienen in:

2017 | OriginalPaper | Buchkapitel

Biomaterials for Induction and Treatment of Autoimmunity

verfasst von : Akhilesh Kumar Shakya, Kutty Selva Nandakumar

Erschienen in: Advances in Biomaterials for Biomedical Applications

Verlag: Springer Singapore

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Use of biomaterials in autoimmunity research is widely explored, as an adjuvant to induce antigen specific immune responses, for facilitating induction of experimental models to study disease pathogenesis and for designing novel therapeutic targets. Similarly, polymeric biomaterials are explored as a delivery vehicle for sustained and specific release of auto-antigens/drugs to treat autoimmune disorders. Although considered as biocompatible, implantation/injection of polymers like silica and metallic implants are associated with development of chronic inflammation and autoimmunity. Despite these compatibility concerns, biomaterials are still considered as favorable materials for several applications in the autoimmunity field.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Plasma Surface Modification of Biomaterials for Biomedical Applications

Nächstes Kapitel Decellularized Tissue Engineering

Alijotas-Reig J (2015) Human adjuvant-related syndrome or autoimmune/inflammatory syndrome induced by adjuvants. Where have we come from? Where are we going? A proposal for new diagnostic criteria. Lupus 24(10):1012–1018CrossRef

Alijotas-Reig J, Garcia-Gimenez V, Llurba E et al (2012) Autoimmune/inflammatory syndrome (ASIA) induced by biomaterials injection other than silicone medical grade. Lupus 21(12):1326–1334CrossRef

Asquith DL, Miller AM, McInnes IB et al (2009) Animal models of rheumatoid arthritis. Eur J Immunol 39(8):2040–2044CrossRef

Balenga NA, Zahedifard F, Weiss R et al (2006) Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy. J Biotechnol 124(3):602–614CrossRef

Beeson PB (1994) Age and sex associations of 40 autoimmune diseases. Am J Med 96(5):457–462CrossRef

Buyuktimkin B, Wang Q, Kiptoo P et al (2012) Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis. Mol Pharm 9(4):979–985CrossRef

Carambia A, Freund B, Schwinge D et al (2015) Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice. J Hepatol 62(6):1349–1356CrossRef

Colia R, Corrado A, Cantatore FP (2016) Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases. Ann Med:1–9

Cooper GS, Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev 2(3):119–125CrossRef

Correale J, Farez M, Gilmore W (2008) Vaccines for multiple sclerosis: progress to date. CNS Drugs 22(3):175–198CrossRef

Descotes J (2004) Immunotoxicology of drugs and chemicals: an experimental and clinical approach. Elsevier, Amsterdam

El-Kamel AH, Sokar MS, Al Gamal SS et al (2001) Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm 220(1–2):13–21CrossRef

Fairweather D (2007) Autoimmune disease: mechanisms. Encyclopedia of Life ScienceS, p 1–6

Franca DC, de Castro AL, Soubhia AM et al (2013) Evaluation of the biocompatibility of silicone gel implants—histomorphometric study. Acta Inform Med 21(2):93–97CrossRef

Gabriel SE, O’Fallon WM, Kurland LT et al (1994) Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 330(24):1697–1702CrossRef

Galperin C, Gershwin ME (1997) Immunopathogenesis of gastrointestinal and hepatobiliary diseases. JAMA 278(22):1946–1955CrossRef

Gammon JM, Tostanoski LH, Adapa AR et al (2015) Controlled delivery of a metabolic modulator promotes regulatory T cells and restrains autoimmunity. J Control Release 210:169–178CrossRef

Gelderman KA, Hultqvist M, Pizzolla A et al (2007) Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 117(10):3020–3028CrossRef

Getts DR, Martin AJ, McCarthy DP et al (2012) Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 30(12):1217–1224CrossRef

Gomez S, Gamazo C, San Roman B et al (2008) Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis. Eur J Pharm Biopharm 70(3):711–717CrossRef

Goren I, Segal G, Shoenfeld Y (2015) Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk? Clin Rheumatol 34(10):1661–1666CrossRef

Hajdu SD, Agmon-Levin N, Shoenfeld Y (2011) Silicone and autoimmunity. Eur J Clin Invest 41(2):203–211CrossRef

Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12(3):204–212CrossRef

Holmdahl R, Sareila O, Olsson LM et al (2016) Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation. Immunol Rev 269(1):228–247CrossRef

Holmich LR, Lipworth L, McLaughlin JK et al (2007) Breast implant rupture and connective tissue disease: a review of the literature. Plast Reconstr Surg 120(7 Suppl 1):62S–69SCrossRef

Hoveizi E, Tavakol S, Ebrahimi-Barough S (2015) Neuroprotective effect of transplanted neural precursors embedded on PLA/CS scaffold in an animal model of multiple sclerosis. Mol Neurobiol 51(3):1334–1342CrossRef

Hunter Z, McCarthy DP, Yap WT et al (2014) A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8(3):2148–2160CrossRef

Hwang J, Rodgers K, Oliver JC et al (2008) Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy. Int J Nanomed 3(3):359–371

Kannan K, Ortmann RA, Kimpel D (2005) Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiol 12(3):167–181CrossRef

Kapoor B, Singh SK, Gulati M et al (2014) Application of liposomes in treatment of rheumatoid arthritis: quo vadis. Sci World J 2014:978351CrossRef

Kawakami N, Lassmann S, Li Z et al (2004) The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J Exp Med 199(2):185–197CrossRef

Ketelhuth DF, Hansson GK (2015) Modulation of autoimmunity and atherosclerosis—common targets and promising translational approaches against disease. Circ J 79(5):924–933CrossRef

Kim WU, Lee WK, Ryoo JW et al (2002) Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. Arthritis Rheum 46(4):1109–1120CrossRef

Kim YJ, Chae SY, Jin CH et al (2010) Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. Biomater 31(34):9057–9064CrossRef

Kumagai Y, Shiokawa Y, Medsger TA Jr et al (1984) Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum 27(1):1–12CrossRef

Lernmark A, Larsson HE (2013) Immune therapy in type 1 diabetes mellitus. Nat Rev Endocrinol 9(2):92–103CrossRef

Liang LS, Jackson J, Min W et al (2004) Methotrexate loaded poly(L-lactic acid) microspheres for intra-articular delivery of methotrexate to the joint. J Pharm Sci 93(4):943–956CrossRef

Liu D, Ge Y, Tang Y et al (2010) Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies. J Microencapsul 27(8):726–734CrossRef

Loyo E, Jara LJ, Lopez PD et al (2013) Autoimmunity in connection with a metal implant: a case of autoimmune/autoinflammatory syndrome induced by adjuvants. Auto Immun Highlights 4(1):33–38CrossRef

Mathew A, Pakan JM, Collin EC et al (2013) An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer. Biomater 34(23):5872–5882CrossRef

Mitchell LA, Lauer FT, Burchiel SW et al (2009) Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol 4(7):451–456CrossRef

Moriuchi-Murakami E, Yamada H, Ishii O et al (2000) Treatment of established collagen induced arthritis with prostaglandin E1 incorporated in lipid microspheres. J Rheumatol 27(10):2389–2396

Nesher G, Soriano A, Shlomai G et al (2015) Severe ASIA syndrome associated with lymph node, thoracic, and pulmonary silicone infiltration following breast implant rupture: experience with four cases. Lupus 24(4–5):463–468CrossRef

Nicholas D, Odumosu O, Langridge WH (2011) Autoantigen based vaccines for type 1 diabetes. Discov Med 11(59):293–301

Petersen LK, Phanse Y, Ramer-Tait AE et al (2012) Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen. Mol Pharm 9(4):874–882CrossRef

Petrovsky N, Aguilar JC (2004) Vaccine adjuvants: current state and future trends. Immunol Cell Biol 82(5):488–496CrossRef

Pizzolla A, Gelderman KA, Hultqvist M et al (2011) CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species. Eur J Immunol 41(2):403–412CrossRef

Pujol-Autonell I, Serracant-Prat A, Cano-Sarabia M et al (2015) Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes. PLoS ONE 10(6):e0127057CrossRef

Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48(10):2741–2749CrossRef

Rosenthal KS, Mikecz K, Steiner HL 3rd et al (2015) Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis. Expert Rev Vaccines 14(6):891–908CrossRef

Ross R (1990) Mechanisms of atherosclerosis–a review. Adv Nephrol Necker Hosp 19:79–86

Ryan JJ, Bateman HR, Stover A et al (2007) Fullerene nanomaterials inhibit the allergic response. J Immunol 179(1):665–672CrossRef

Sakai T, Kohno H, Ishihara T et al (2006) Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res 82(4):657–663CrossRef

Sanchez-Guerrero J, Colditz GA, Karlson EW et al (1995) Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med 332(25):1666–1670CrossRef

Scott MD, Murad KL (1998) Cellular camouflage: fooling the immune system with polymers. Curr Pharm Des 4(6):423–438

Scott MD, Murad KL, Koumpouras F et al (1997) Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci U S A 94(14):7566–7571CrossRef

Shakya AK, Holmdahl R, Nandakumar KS et al (2013) Characterization of chemically defined poly-N-isopropylacrylamide based copolymeric adjuvants. Vaccine 31(35):3519–3527CrossRef

Shakya AK, Kumar A, Holmdahl R et al (2016) Macrophage-derived reactive oxygen species protects against autoimmune priming with a defined polymeric adjuvant. Immunol 147(1):125–132CrossRef

Shakya AK, Kumar A, Klaczkowska D et al (2011) Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes. Am J Pathol 179(5):2490–2500CrossRef

Shakya AK, Nandakumar KS (2012a) Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases. J R Soc Interface 10(79):20120536CrossRef

Shakya AK, Nandakumar KS (2012b) Polymers as immunological adjuvants: an update on recent developments. J BioSci Biotech 3:199–210

Shakya AK, Nandakumar KS (2015) Synthetic polymer as an adjuvant in collagen-induced arthritis. Curr Protoc Mouse Biol 4(1):11–24

Singh M, Solomon IH, Calderwood MS et al (2016) Silicone-induced Granuloma After Buttock Augmentation. Plast Reconstr Surg Glob Open 4(2):e624CrossRef

Singh S, Gajra B, Rawat M et al (2009) Enhanced transdermal delivery of ketoprofen from bioadhesive gels. Pak J Pharm Sci 22(2):193–198

Smith DA, Germolec DR (1999) Introduction to immunology and autoimmunity. Environ Health Perspect 107(Suppl 5):661–665CrossRef

So T, Ito HO, Koga T et al (1996) Reduced immunogenicity of monomethoxypolyethylene glycol-modified lysozyme for activation of T cells. Immunol Lett 49(1–2):91–97CrossRef

Soehngen EC, Godin-Ostro E, Fielder FG et al (1988) Encapsulation of indomethacin in liposomes provides protection against both gastric and intestinal ulceration when orally administered to rats. Arthritis Rheum 31(3):414–422CrossRef

Spiera RF, Gibofsky A, Spiera H (1994) Silicone gel filled breast implants and connective tissue disease: an overview. J Rheumatol 21(2):239–245

Suda K, Yanai T, Kawakami H et al (2016) Deterioration of autoimmune condition associated with repeated injection of dextranomer/hyaluronic acid copolymer: a case report. J Ped Surg Case Reports 4:10–12CrossRef

van Belle TL, Coppieters KT, von Herrath MG (2011) Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91(1):79–118CrossRef

van Nunen SA, Gatenby PA, Basten A (1982) Post-mammoplasty connective tissue disease. Arthritis Rheum 25(6):694–697CrossRef

Yang F, Kamiya N, Goto M (2012) Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier. Eur J Pharm Biopharm 82(1):158–163CrossRef

Yednock TA, Cannon C, Fritz LC et al (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nat 356(6364):63–66CrossRef

Yoon YM, Lewis JS, Carstens MR et al (2015) A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice. Sci Rep 5:13155CrossRef

Titel: Biomaterials for Induction and Treatment of Autoimmunity
verfasst von: Akhilesh Kumar Shakya
Kutty Selva Nandakumar
Verlag: Springer Singapore
Buch: Advances in Biomaterials for Biomedical Applications
Print ISBN: 978-981-10-3327-8

Electronic ISBN: 978-981-10-3328-5

Copyright-Jahr: 2017
DOI: https://doi.org/10.1007/978-981-10-3328-5_4

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht